G2 Basic Guide to FCA Compliance for Clinical Labs

Now Available from the G2 Master Compliance Series:

G2 Basic Guide to FCA Compliance for Clinical Labs

Practical “How-to” Help to Comply with the False Claims Act and Avoid Costly Fines and Penalties

The federal False Claims Act (FCA) is the U.S. government’s primary and most potent civil health care fraud enforcement tool.

FCA actions against health care providers have earned the government $47 billion in total recoveries since 2010, and clinical labs are a primary target of FCA enforcement investigations.

To help your lab navigate this important but complex Act, avoid compliance pitfalls, and sidestep significant fines and even criminal penalties, G2 Intelligence has just released an important new 34-page Special Report: G2 Basic Guide to FCA Compliance for Clinical Labs.

Here is just a sample of the help your new Special Report delivers:

  • What Is the False Claims Act: Recoveries Against Health Care Providers, What Is a “False Claim”, Key Terms Lab Professionals Need to Understand, Kickbacks as False Claims, AKS Violations, Reverse False Claims and the 60-Day Repayment Rule, Impact of the ACA on False and Fraudulent Claims, CMS Final Rule and When the 60-Day Clock Starts Running, When an Overpayment is Considered “Identified”, FCA Look-Back Period, How Repayments Must be Achieved, Demonstrating “Reasonable Diligence”, 6 Examples of Identified Overpayments, OIG Self-Disclosure Protocol, CMS Voluntary Self-Referral Disclosure Protocol
  • False Claims Based on Implied Certification: What is “Implied False Certification”, Impact of Universal Health Services, Inc. vs Escobar, Omission of Material Statutory, Regulatory, of Contractual Requirement, When Omission Makes a Claim Fraudulent
  • FCA Penalties: Increased Minimum Penalties for FCA Violations, Inflation Indexing for Penalties, Determining Which Annual Penalty Rate Applies, Liability for Treble Damages: “Three Times the Amount of Damages the Government Sustains”, Exclusion from Medicare: the FCA Violation “Death Penalty”, The Program Integrity Enhancements to the Provider Enrollment Process, Liability and the Employee Lookback Rule, Which Employees Fall Under the Lookback Rule, Required Employee Disclosures, 4 Situations When CMS Can Revoke or Deny Medicare Participation, Other CMS Penalties Under the Final Rule
  • FCA Penalties & the OIG Fraud Risk Indicator System: How the New Fraud Risk Indicator System (FRI) Works, When the FRI Comes Into Play, The FRI and Corporate Integrity Agreements (CIAs), The 5 OIG FRI Risk Categories, Specific Compliance Measures CIAs May Include
  • Whistleblowers and Qui Tam Lawsuits: The Idea Behind Qui Tams, Why Qui Tams Account For A Growing Percent of FCA Recoveries, The Granston Memo, 7 Factors U.S. Attorneys Consider for Dismissal of Whistleblower Suits, How Qui Tam Lawsuits Work, Barriers to Qui Tam Lawsuits, Statues Of Limitation On Qui Tam Lawsuits, FCA Anti-Retaliation Provisions, Preventing Qui Tam Complaints, Responding to Qui Tam Complaints, What A Good Qui Tam Policy Should Include

Make No Mistake: It is absolutely imperative that EVERY clinical lab professional understands the FCA.  The penalties for violations can be staggering.  This new Special Report gives you the practical, plain-language help you need to understand the FCA, and take practical, proven steps to protect your lab from costly fines and penalties.

Get this 34 page PDF now by adding to cart or by calling Customer Service at 855-528-6903.

For multi-user/multi-location pricing, please contact Sokha Pearson at 855-528-6903 or via email at spearson@g2intelligence.com.